Nasopalpebral lipoma-coloboma syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2399OMIM:167730Q10.3
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Nasopalpebral lipoma-coloboma syndrome (also known as Penchaszadeh syndrome) is an extremely rare congenital disorder characterized by the combination of congenital upper eyelid colobomas (notch-like defects in the eyelids) and symmetrical lipomas (benign fatty growths) affecting the nose and eyelids. The condition is present at birth and primarily affects structures of the face, particularly the eyes and nose. Key clinical features include bilateral upper eyelid colobomas, nasopalpebral lipomas that may extend from the inner corners of the eyes across the bridge of the nose, telecanthus (widely spaced inner corners of the eyes), and a broad nasal bridge. Some patients may also have additional findings such as sparse or absent eyebrows medially, and mild facial dysmorphism. Vision may be affected depending on the severity of the eyelid colobomas, which can lead to corneal exposure and associated complications if left untreated. The syndrome was first described by Penchaszadeh in 1982. It appears to follow an autosomal dominant inheritance pattern, though the underlying genetic cause has not been fully elucidated. The condition has been reported in a very small number of families worldwide. Treatment is primarily surgical and supportive, focusing on repair of the eyelid colobomas to protect the cornea and preserve vision, as well as cosmetic removal of the lipomas if desired. Early ophthalmologic evaluation is important to prevent corneal damage. With appropriate surgical management, the prognosis is generally favorable, as the condition does not typically involve systemic or life-threatening complications.

Clinical phenotype terms— hover any for plain English:

Lacrimal punctal atresiaHP:0007820Widow's peakHP:0000349Depressed nasal tipHP:0000437Severe postnatal growth retardationHP:0008850
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Nasopalpebral lipoma-coloboma syndrome.

View clinical trials →

No actively recruiting trials found for Nasopalpebral lipoma-coloboma syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Nasopalpebral lipoma-coloboma syndrome community →

No specialists are currently listed for Nasopalpebral lipoma-coloboma syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Nasopalpebral lipoma-coloboma syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Nasopalpebral lipoma-coloboma syndromeForum →

No community posts yet. Be the first to share your experience with Nasopalpebral lipoma-coloboma syndrome.

Start the conversation →

Latest news about Nasopalpebral lipoma-coloboma syndrome

No recent news articles for Nasopalpebral lipoma-coloboma syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Nasopalpebral lipoma-coloboma syndrome

What is Nasopalpebral lipoma-coloboma syndrome?

Nasopalpebral lipoma-coloboma syndrome (also known as Penchaszadeh syndrome) is an extremely rare congenital disorder characterized by the combination of congenital upper eyelid colobomas (notch-like defects in the eyelids) and symmetrical lipomas (benign fatty growths) affecting the nose and eyelids. The condition is present at birth and primarily affects structures of the face, particularly the eyes and nose. Key clinical features include bilateral upper eyelid colobomas, nasopalpebral lipomas that may extend from the inner corners of the eyes across the bridge of the nose, telecanthus (wide

How is Nasopalpebral lipoma-coloboma syndrome inherited?

Nasopalpebral lipoma-coloboma syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Nasopalpebral lipoma-coloboma syndrome typically begin?

Typical onset of Nasopalpebral lipoma-coloboma syndrome is neonatal. Age of onset can vary across affected individuals.